NextCure, Inc. - 10-Q Filing
NextCure reported a net loss of $9.8 million for the three months ended March 31, 2026, compared to a $10.976 million loss in the same period last year. The company's cash and equivalents decreased from $25.982 million at December 31, 2025, to $15.167 million as of March 31, 2026.
Tickers: $NXTC